Nicholas Investment Partners, LP Repligen Corp Transaction History

Nicholas Investment Partners, LP

$900 Million
Q3 2024

A detailed history of Nicholas Investment Partners, LP transactions in Repligen Corp stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 43,782 shares of RGEN stock, worth $6.42 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

43,782

Holding current value

$6.42 Million

% of portfolio

0.72%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$119.79 - $167.35 $5.24 Million - $7.33 Million	43,782 New	43,782 $6.52 Million
Q4 2022 Feb 10, 2023	SELL	$162.42 - $220.56 $38,168 - $51,831	-235 Reduced 0.27%	87,487 $14.8 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $3.86 Million - $6.16 Million	-24,057 Reduced 21.52%	87,722 $16.4 Million
Q2 2022 Aug 10, 2022	SELL	$140.68 - $188.02 $732,661 - $979,208	-5,208 Reduced 4.45%	111,779 $18.2 Million
Q1 2022 May 10, 2022	BUY	$161.19 - $257.96 $3.1 Million - $4.96 Million	19,235 Added 19.68%	116,987 $22 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $2.26 Million - $2.78 Million	9,131 Added 10.3%	97,752 $25.9 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $9.35 Million - $15.6 Million	-48,031 Reduced 35.15%	88,621 $25.6 Million
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $904,157 - $1.2 Million	-5,451 Reduced 3.84%	136,652 $27.3 Million
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $2.09 Million - $2.63 Million	11,612 Added 8.9%	142,103 $27.6 Million
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $42,943 - $59,905	290 Added 0.22%	130,491 $25 Million
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $12.2 Million - $15.8 Million	99,540 Added 324.65%	130,201 $19.2 Million
Q2 2020 Aug 12, 2020	SELL	$94.33 - $140.48 $3.53 Million - $5.26 Million	-37,461 Reduced 54.99%	30,661 $3.79 Million
Q1 2020 May 13, 2020	SELL	$84.96 - $109.14 $792,506 - $1.02 Million	-9,328 Reduced 12.04%	68,122 $6.58 Million
Q4 2019 Feb 13, 2020	SELL	$73.84 - $93.08 $4.24 Million - $5.35 Million	-57,454 Reduced 42.59%	77,450 $7.16 Million
Q3 2019 Nov 13, 2019	BUY	$76.65 - $95.51 $6.02 Million - $7.5 Million	78,484 Added 139.11%	134,904 $10.3 Million
Q2 2019 Aug 09, 2019	SELL	$54.2 - $85.95 $17,452 - $27,675	-322 Reduced 0.57%	56,420 $4.85 Million
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $489,011 - $621,029	-9,889 Reduced 14.84%	56,742 $3.35 Million
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $16,215 - $23,143	-336 Reduced 0.5%	66,631 $3.51 Million
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $1.14 Million - $1.44 Million	-24,386 Reduced 26.69%	66,967 $3.71 Million
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $232,680 - $310,416	6,599 Added 7.79%	91,353 $4.3 Million
Q1 2018 May 15, 2018	BUY	$30.92 - $37.27 $934,711 - $1.13 Million	30,230 Added 55.44%	84,754 $3.07 Million
Q4 2017 Feb 14, 2018	SELL	$32.53 - $38.92 $821,349 - $982,691	-25,249 Reduced 31.65%	54,524 $1.98 Million
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $2.95 Million - $3.67 Million	79,773	79,773 $3.06 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.13B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Account

Nicholas Investment Partners, LP Repligen Corp Transaction History